Pennymac Mortgage Investment Trust (PMT) concluded trading on Thursday at a closing price of $13.23, with 0.48 million shares of worth about $6.34 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 6.35% during that period and on July 03, 2025 the price remained unchanged. Currently the company’s common shares owned by public are about 87.01M shares, out of which, 86.15M shares are available for trading.
Stock saw a price change of 2.64% in past 5 days and over the past one month there was a price change of 8.09%. Year-to-date (YTD), PMT shares are showing a performance of -2.72% which increased to 5.08% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $11.77 but also hit the highest price of $14.98 during that period. The average intraday trading volume for Pennymac Mortgage Investment Trust shares is 888.51K. The stock is currently trading 4.36% above its 20-day simple moving average (SMA20), while that difference is up 4.79% for SMA50 and it goes to -1.04% lower than SMA200.
Pennymac Mortgage Investment Trust (NYSE: PMT) currently have 87.01M outstanding shares and institutions hold larger chunk of about 72.49% of that.
The stock has a current market capitalization of $1.15B and its 3Y-monthly beta is at 1.22. PE ratio of stock for trailing 12 months is 14.21, while it has posted earnings per share of $0.93 in the same period. Its PEG reads 2.69 and has Quick Ratio of 0.05 while making debt-to-equity ratio of 6.64. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PMT, volatility over the week remained 2.01% while standing at 1.85% over the month.
Stock’s fiscal year EPS is expected to drop by -20.00% while it is estimated to increase by 42.62% in next year. EPS is likely to grow at an annualized rate of 5.28% for next 5-years, compared to annual growth of -10.82% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Keefe Bruyette on July 10, 2024 offering an Outperform rating for the stock and assigned a target price range of between $15 and $15.50 to it. Stock get a Neutral rating from Piper Sandler on February 07, 2023.
